Gerd Sutter
11Patents
6h-index
9Co-inventors
59Inventor score
Filing activity: Sep 23, 1997 → Mar 28, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6440422B1 | Recombinant MVA virus, and the use thereof | Emerging Cross-Sectional Technologies | 44 | Expired |
| US7049145B2 | Vaccinia virus MVA-E3L-knockout-mutants and use thereof | Emerging Cross-Sectional Technologies | 19 | Expired |
| US8197825B2 | Recombinant MVA virus and the use thereof | Emerging Cross-Sectional Technologies | 18 | Active |
| US6682742B1 | Vector for integration of heterologous sequences into poxviral genomes | Chemistry; Metallurgy | 17 | Expired |
| US6869793B2 | Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7767209B2 | Modified vaccinia virus Ankara (MVA) mutant and use thereof | Emerging Cross-Sectional Technologies | 6 | Expired |
| US11633441B2 | Immuno-modulated replication-efficient vaccinia virus strain | Chemistry; Metallurgy | 1 | Active |
| US8153138B2 | Recombinant MVA virus | Emerging Cross-Sectional Technologies | 1 | Active |
| US7198934B2 | Recombinant MVA virus, and the use thereof | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7150874B2 | Vector for integration of heterologous sequences into poxviral genomes | Chemistry; Metallurgy | 0 | Expired |
| US12295979B2 | Immuno-modulated replication-efficient Vaccinia virus strain | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.